Literature DB >> 10517310

Antiviral properties of isoborneol, a potent inhibitor of herpes simplex virus type 1.

M Armaka1, E Papanikolaou, A Sivropoulou, M Arsenakis.   

Abstract

Isoborneol, a monoterpene and a component of several plant essential oils, showed dual viricidal activity against herpes simplex virus 1 (HSV-1). First, it inactivated HSV-1 by almost 4 log10 values within 30 min of exposure, and second, isoborneol at a concentration of 0.06% completely inhibited viral replication, without affecting viral adsorption. Isoborneol did not exhibit significant cytotoxicity at concentrations ranging between 0.016% and 0.08% when tested against human and monkey cell lines. Isoborneol specifically inhibited glycosylation of viral polypeptides based on the following data: (1) the mature fully glycosylated forms of two viral glycoproteins gB and gD were not detected when the virus was replicated in the presence of isoborneol, (2) no major changes were observed in the glycosylation pattern of cellular polypeptides between untreated and isoborneol treated Vero cells, (3) isoborneol did not affect the glycosylation of gB produced from a copy of the gB gene resident in the cellular genome, and (4) other monoterpenes such as 1,8-cineole and borneol, a stereoisomer of isoborneol, did not inhibit HSV-1 glycosylation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10517310     DOI: 10.1016/s0166-3542(99)00036-4

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  19 in total

1.  Mechanisms of antiviral action of plant antimicrobials against murine norovirus.

Authors:  Damian H Gilling; Masaaki Kitajima; Jason R Torrey; Kelly R Bright
Journal:  Appl Environ Microbiol       Date:  2014-06-06       Impact factor: 4.792

Review 2.  Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs.

Authors:  Nunzio Iraci; Carmelo Corsaro; Salvatore V Giofrè; Giulia Neri; Angela Maria Mezzasalma; Martina Vacalebre; Antonio Speciale; Antonina Saija; Francesco Cimino; Enza Fazio
Journal:  Biomolecules       Date:  2022-07-30

Review 3.  Chemical Constituents of Essential Oils Used in Olfactory Training: Focus on COVID-19 Induced Olfactory Dysfunction.

Authors:  Sachiko Koyama; Thomas Heinbockel
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

4.  Antiviral activity of monoterpenes beta-pinene and limonene against herpes simplex virus in vitro.

Authors:  Akram Astani; Paul Schnitzler
Journal:  Iran J Microbiol       Date:  2014-06

Review 5.  Antimicrobial Properties of Plant Essential Oils against Human Pathogens and Their Mode of Action: An Updated Review.

Authors:  Mallappa Kumara Swamy; Mohd Sayeed Akhtar; Uma Rani Sinniah
Journal:  Evid Based Complement Alternat Med       Date:  2016-12-20       Impact factor: 2.629

Review 6.  Essential Oils and Health.

Authors:  J Tyler Ramsey; B Carrie Shropshire; Tibor R Nagy; Kevin D Chambers; Yin Li; Kenneth S Korach
Journal:  Yale J Biol Med       Date:  2020-06-29

7.  Screening for antiviral activities of isolated compounds from essential oils.

Authors:  Akram Astani; Jürgen Reichling; Paul Schnitzler
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-14       Impact factor: 2.629

8.  Glycerosome of Melissa officinalis L. Essential Oil for Effective Anti-HSV Type 1.

Authors:  Giulia Vanti; Sotirios G Ntallis; Christos A Panagiotidis; Virginia Dourdouni; Christina Patsoura; Maria Camilla Bergonzi; Diamanto Lazari; Anna Rita Bilia
Journal:  Molecules       Date:  2020-07-08       Impact factor: 4.411

9.  N-Heterocyclic borneol derivatives as inhibitors of Marburg virus glycoprotein-mediated VSIV pseudotype entry.

Authors:  A A Kononova; A S Sokolova; S V Cheresiz; O I Yarovaya; R A Nikitina; A A Chepurnov; A G Pokrovsky; N F Salakhutdinov
Journal:  Medchemcomm       Date:  2017-10-19       Impact factor: 3.597

10.  Synthesis and in vitro study of novel borneol derivatives as potent inhibitors of the influenza A virus.

Authors:  A S Sokolova; O I Yarovaya; M D Semenova; A A Shtro; I R Orshanskaya; V V Zarubaev; N F Salakhutdinov
Journal:  Medchemcomm       Date:  2017-03-03       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.